Reference : Clinical PET in Oncology
Parts of books : Contribution to collective works
Human health sciences : Oncology
Human health sciences : Radiology, nuclear medicine & imaging
http://hdl.handle.net/2268/14708
Clinical PET in Oncology
English
Rigo, Pierre mailto [Université de Liège - ULg > Département des sciences de la motricité > Pathologie générale et médecine nucléaire >]
Paulus, Patrick [> >]
Bury, Thierry mailto [Centre Hospitalier Universitaire de Liège - CHU > > Pneumologie-Allergologie >]
Jerusalem, Guy mailto [Centre Hospitalier Universitaire de Liège - CHU > > Oncologie médicale >]
Hustinx, Roland mailto [Université de Liège - ULg > Département des sciences cliniques > Médecine nucléaire >]
Benoit, Thérèse [> >]
Larock, Marie-Paule mailto [Centre Hospitalier Universitaire de Liège - CHU > > Médecine nucléaire >]
Willems, Jacqueline mailto [Centre Hospitalier Universitaire de Liège - CHU > > Médecine nucléaire >]
1997
Radioactive Isotopes in Clinical Medicine and Research
Bergmann, H.
Kroiss, A.
Sinzinger H
Birhauser Verlag
3-14
No
Basel
Suisse
[en] PET ; FDG ; Oncology
[en] 18-FDG is accumulated in cancer cells. It has been proven useful to image a variety of tumors in conjunction with whole-body positron emission tomography. This review details somes of the indications of PET at various stages of the cancerous process : differential diagnosis, preoperative staging, diagnosis of residual or recurrent disease as well as follow-up of therapy. Consideration of several potential improvements in clinical PET and of the need for careful patients selection conclude this review.
http://hdl.handle.net/2268/14708

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Rigo P et al, Radioactive Isotopes in Clinical Medicine and Research, 1997.pdfPublisher postprint482.44 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.